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Introduction
Changes within the MRSA population of single hospitals
have been observed with certain clones replacing others.
Surveillance of the genetic diversity within a hospital
provides useful epidemiological data. Staphylococcal
chromosomic cassettes (SCCmec) of MRSA isolates are
routinely determined at HUG.
Objectives
To describe secular trends of the predominant MRSA
clones retrieved at HUG from 2003-12 using SCCmec
genotyping.
Methods
Since 2005, the SCCmec in MRSA isolates (screening
swabs or clinical samples) were routinely assessed by mul-
tiplex PCR assay. MLVA was used to evaluate genomic
diversity; representative isolates were grouped in MLVA
clusters and subjected to MLST. All patients’ 1st positive
MRSA isolate/year was analysed. Frequency distributions
and hospital-acquired (HA)-MRSA rates were determined.
Results
HA-MRSA cases/100 admissions increased from 1.36
(2000) to 2.00 (2006) and declined to 0.79 (2012). Overall,
9717 MRSA isolates underwent SCCmec genotyping.
SCCmecI, the predominant cassette during the study per-
iod, peaked at 88% in 2003 and declined to 64% in 2012.
SCCmecIV increased modestly from 10% to 16%, followed
by SCCmecII with a strong increasing trend from 2% to
14%. Other types were minor contributors (SCCmecV,
3.4%; others <2%). Patients harboring SCCmecI and
SCCmecII were older (median age, 76 and 82 y) compared
to those with SCCmecIV (60 y). Strain distribution dif-
fered by hospital sectors. While SCCmecI remained the
prevalent subtype in acute care (AC) and non-AC settings,
the proportion of MRSA containing SCCmecII and
SCCmecIV was higher in non-AC settings. SCCmecII
increased from 6% to 32% in geriatrics. Genotyping con-
firmed ST228 South German-SCCmecI as the predomi-
nant clone. ST105 (CC5) appears to be the predominant
clone of SCCmecII. Individual SCCmec replacement was
observed in 123 patients (incl. 37 within SCCmecI-
SCCmecII and 69, SCCmecI-SCCmecIV).
Conclusion
ST 228 SCCmecI is still the predominant clone in all
settings, but decaying. The prevalence of SCCmecII is
higher in geriatrics than in AC settings. The emerging
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